Europe — EMA
Paliperidone Teva (Paliperidone Palmitate)
Paliperidone palmitate, the active ingredient in Paliperidone Teva, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use.
Request sourcing
What is Paliperidone Palmitate?
Paliperidone palmitate, the active ingredient in Paliperidone Teva, is an atypical antipsychotic presented as a long‑acting injectable suspension for intramuscular use. It is used to treat schizophrenia and related psychotic disorders in adults.
GNH USA supplies Paliperidone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.
What is Paliperidone Palmitate used for?
Paliperidone palmitate is an atypical antipsychotic indicated for the management of psychotic disorders within the schizophrenia spectrum. - Schizophrenia: Reduces risk of relapse and controls acute psychotic symptoms. - Schizoaffective disorder: Stabilises mood and psychotic features. - Maintenance therapy after acute episode: Provides sustained symptom control with monthly dosing.
What are the side effects of Paliperidone Palmitate?
Side effects associated with paliperidone palmitate vary in frequency and severity.
Common Side Effects: - Injection site pain or erythema - Weight gain - Fatigue or somnolence - Restlessness (akathisia) - Increased prolactin levels - Constipation
Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe orthostatic hypotension - Seizures - Hyperglycaemia or new‑onset diabetes - Allergic reactions including anaphylaxis
What precautions apply to Paliperidone Palmitate?
When prescribing Paliperidone palmitate, clinicians should consider several important precautions. - Monitor blood pressure : Regular monitoring of the systolic and the diastolic d a a t \
